收稿日期: 2019-10-09
网络出版日期: 2021-02-07
基金资助
中国医学科学院医学与健康科技创新工程项目(2019-I2M-5-038);北京市自然科学基金(7102101)
Clinicopathological analysis of mucosa associated lymphoid tissue lymphoma secondary to Sjögren’s syndrome in salivary gland
Received date: 2019-10-09
Online published: 2021-02-07
Supported by
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences(2019-I2M-5-038);Beijing Natural Science Foundation(7102101)
目的: 分析唾液腺干燥综合征(Sj?gren’s syndrome,SS)继发黏膜相关淋巴组织(mucosa associated lym-phoid tissue,MALT)淋巴瘤(SS-MALT淋巴瘤)的临床病理特点,并探索联合应用组织病理形态、蛋白表达和分子表型检测在唾液腺SS-MALT淋巴瘤病理诊断和预后评估中的应用价值。方法: 在1997年1月至2016年12月就诊于北京大学口腔医院并经病理确诊为唾液腺SS的260例患者中收集到16例SS-MALT淋巴瘤患者,另选取12例无唾液腺SS病史的MALT淋巴瘤(非SS-MALT淋巴瘤)患者作为对照,回顾性分析患者临床资料并随访。同时,应用苏木精-伊红染色、免疫组织化学、聚合酶链式反应(polymerase chain reaction,PCR)和荧光原位杂交技术(fluorescence in situ hybridization,FISH)观察组织病理变化,检测轻链限制性表达、免疫球蛋白(immunoglobulin,Ig)基因重排、染色体易位及基因异常,评价其在病理诊断和预后判断中的作用。结果: SS进展为MALT淋巴瘤的恶变率约为6.15%,恶变时间为3~240个月不等,其中有2例因发生高级别转化而死亡。SS-MALT淋巴瘤镜下表现为腺泡不同程度的萎缩破坏,以中心细胞样细胞为主的淋巴细胞弥漫浸润并破坏上皮岛。SS-MALT淋巴瘤组CD20和Pax5均为阳性(阳性率100%);Ki-67指数≤10%者占50%,>10%者占50%;AE1/AE3染色显示有残存腺上皮(93.75%)。全部病例肿瘤细胞CD3ε均为阴性,CD138染色显示有数量不等的浆细胞。37.5%的SS-MALT淋巴瘤患者检测到κ和λ轻链限制性表达。SS-MALT淋巴瘤组中免疫球蛋白重链(immunoglobulin heavy chain,IgH)-FR1、IgH-FR2、IgH-FR3、免疫球蛋白κ链(immunoglobulin kappa chain,IgK)-A、IgK-B的阳性检出率分别为33.3%、53.3%、33.3%、20.0%、26.7%,联合应用IgH和IgK的阳性检出率达93.3%。MALT1双色分离探针阳性率36.4%,IGH双色分离探针阳性率27.3%,BCL6双色分离探针阳性率27.3%;三种探针共同使用的基因异常检出率为72.7%。结论: 唾液腺SS-MALT淋巴瘤的病理诊断缺乏特异性的组织形态特点和蛋白表型,联合应用组织形态观察、免疫组织化学、PCR和FISH技术有助于该疾病的精准病理诊断。同时,虽然SS-MALT淋巴瘤一般被认为是惰性淋巴瘤,预后较好,但也应定期复诊和长期随访,以便早发现复发和高级别化的线索,提高患者的生存率。
池彦廷 , 张延平 , 张秋露 , 刘翠苓 , 李斌斌 . 唾液腺干燥综合征继发黏膜相关淋巴组织淋巴瘤的临床病理分析[J]. 北京大学学报(医学版), 2021 , 53(1) : 40 -45 . DOI: 10.19723/j.issn.1671-167X.2021.01.007
Objective: To analyze the clinicopathological characteristics of mucosa associated lymphoid tissue (MALT) lymphoma secondary to Sj?gren’s syndrome (SS) (SS-MALT lymphoma) in salivary gland and to explore the value of the combined application of histopathological morphology, protein expression and molecular phenotype in pathological diagnosis and prognostic evaluation of SS-MALT lymphoma.Methods: Sixteen patients with SS-MALT lymphoma were collected from 260 patients who were diagnosed with SS in Peking University School and Hospital of Stomatology from January 1997 to December 2016. Twelve patients with non-MALT lymphoma secondary to SS (non-SS-MALT lymphoma) in salivary gland were selected as controls. The clinical data of the patients were retrospectively reviewed and analyzed. All the patients were followed up until December 20, 2019. Hematoxylin-eosin staining, immunohistochemistry, polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH) techniques were used to observe the histologic characteristics and to detect the manifestations of light chain restrictive expression, immunoglobulin (Ig) gene clonal rearrangement, chromosome translocation and gene abnormality, so as to evaluate their values in pathological diagnosis and prognostic evaluation.Results: The malignant transformation rate of SS to MALT lymphoma was about 6.15%, ranged from 3 to 240 months, during which 2 patients died due to high-level deterioration. Microscopically, the acini of the glandular tissue were atrophied and destroyed. The tumor cells dominated by central cell-like lymphocytes grew diffusely, destroying the epithelial islands. All SS-MALT lymphoma cases were positive in CD20 and Pax5. Half of them had the Ki-67 proliferation index of 10% or less, and half greater than 10%. 93.75% cases expressed AE1/AE3 protein, which showed the residual glandular epithelium. All the tumor cells were negative in CD3ε, and the plasma cells were detected by CD138 antigen. The light chain restrictive expression of κ and λ was 37.5% in SS-MALT lymphoma group. The positive detection rates of immunoglobulin heavy chain (IgH)-FR1, IgH-FR2, IgH-FR3, immunoglobulin kappa chain (IgK)-A, and IgK-B in SS-MALT lymphoma group were 33.3%, 53.3%, 33.3%, 20.0%, and 26.7%, respectively, and 93.3% when together used with IgH and IgK. The positive rates of the MALT1, IGH and BCL6 genes with dual color break-apart probes were 36.4%, 27.3% and 27.3%, and the detection rate of chromosome translocation and gene abnormality by applying the three probes was 72.7%.Conclusion: There are no specific histological characteristics and protein phenotypes in the histologic diagnosis of SS-MALT lymphoma in salivary gland. The combined application of histopathological manifestations, immunohistochemistry, PCR and FISH techniques helps the accurate pathologic diagnosis of the disease. Although SS-MALT lymphoma is considered as an indolent lymphoma with a relatively favorable prognosis, the regular return visit and long-term follow-up should be conducted to detect the clues of recurrence and advanced deterioration.
| [1] | Isaacson PG, Wright DH. Malignant lymphoma of mucosa associate lymphoid tissue: A distinctive type of B cell lymphoma[J]. Cancer, 1983,52(8):1410-1416. |
| [2] | Isaacson PG, Chott A, Nakamura S, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) [M]//WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: LARC Press, 2008: 214-217. |
| [3] | Cohen SM, Petryk M, Varma M, et al. Non-Hodgkin’s lymphoma of mucosa-associated lymphoid tissue[J]. Oncologist, 2006,11(10):1100-1117. |
| [4] | Hirokawa Y, Fujikawa R, Arai Y, et al. Primary thymic MALT lymphoma in a patient with Sj?gren’s syndrome and multiple lung cysts: A case report[J]. Surg Case Rep, 2019,5(1):138. |
| [5] | Titsinides S, Nikitakis N, Piperi E, et al. MALT lymphoma of minor salivary glands in a Sj?gren’s syndrome patient: A case report and review of literature[J]. J Oral Maxillofac Res, 2017,8(1):e5. |
| [6] | Jackson AE, Mian M, Kalpadakis C, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue of the salivary glands: A multicenter, international experience of 248 patients (IELSG 41)[J]. Oncologist, 2015,20(10):1149-1153. |
| [7] | De Vita S, Gandolfo S. Predicting lymphoma development in patients with Sj?gren’s syndrome[J]. Expert Rev Clin Immunol, 2019,15(9):929-938. |
| [8] | Vitali C, Bombardieri S, Jnnsson R, et al. Classification criteria for Sj?gren’s syndrome: A revised version of the European criteria proposed by the American-European Consensus Group[J]. Ann Rheum Dis, 2002,61(6):554-558. |
| [9] | A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The non-Hodgkin’s lymphoma classification project[J]. Blood, 1997,89(11):3909-3918. |
| [10] | Spencer J, Diss T, Isaacson PG. A study of the properties of a low-grade mucosal B-cell lymphoma using a monoclonal antibody specific for the tumour immunoglobulin[J]. J Pathol, 1990,160(3):231-238. |
| [11] | 徐卫. 小B细胞淋巴瘤的诊断[J]. 临床内科杂志, 2015,32(3):163-165. |
| [12] | 刘霜竹, 张艳青, 郁多男, 等. 转录因子Pax5 可不依赖与启动子结合促进B细胞淋巴瘤生长[J]. 中国实验血液学杂志, 2017,25(6):1652-1657. |
| [13] | Xue K, Song JZ, Yang Y, et al. PAX5 promotes pre-B cell proli-feration by regulating the expressionof pre-B cell receptor and its downstream signaling[J]. Mol Immunol, 2016,73:1-9. |
| [14] | 王红霞, 陈昊, 林海月, 等. MALToma Ig重链蛋白、IgH基因重排/断裂检测的临床意义[J]. 临床与实验病理学杂志, 2019,35(8):902-906. |
| [15] | Weiss LM, Spagnolo DV. Assessment of clonality in lymphoid proliferation[J]. Am J Pathol, 1993,142(6):1679-1682. |
| [16] | Chen YL, Su IJ, Cheng HY, et al. BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan[J]. Leuk Lymphoma, 2010,51(4):650-655. |
| [17] | Halldórsdóttir AM, Zehnbauer BA, Burack WR. Application of BIOMED-2 clonality assays to formalin-fixed paraffin embedded follicular lymphoma specimens: Superior performance of the IGK assays compared to IGH for suboptimal specimens[J]. Leuk Lymphoma, 2007,48(7):1338-1343. |
| [18] | Du MQ. MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism[J]. Best Pract Res Clin Haematol, 2017,30(1-2):13-23. |
| [19] | Raderer M, Kiesewetter B, Ferreri AJ. Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)[J]. CA Cancer J Clin, 2016,66(2):153-171. |
| [20] | Ye H, Reinstein ED, Bacon CM, et al. Chromosomal translocations involving BCL6 in MALT lymphoma[J]. Haematologlca, 2008,93(1):145-146. |
| [21] | 何晨, 毛峥嵘. FISH 技术在淋巴瘤分子特征中的研究和应用进展[J]. 中国肿瘤临床, 2013,40(10):608-611. |
| [22] | 林海月, 王红霞, 陈昊. 黏膜相关淋巴组织淋巴瘤诊断进展[J]. 临床与实验病理学杂志, 2017,33(9):1010-1012. |
/
| 〈 |
|
〉 |